日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/23 | 6,550 | 6,580 | 6,480 | 6,510 | +80 | +1.2% | 231,700 |
| 2023/05/22 | 6,460 | 6,480 | 6,380 | 6,430 | +20 | +0.3% | 166,200 |
| 2023/05/19 | 6,350 | 6,430 | 6,320 | 6,410 | +60 | +0.9% | 258,400 |
| 2023/05/18 | 6,430 | 6,450 | 6,300 | 6,350 | -10 | -0.2% | 260,400 |
| 2023/05/17 | 6,400 | 6,440 | 6,350 | 6,360 | -40 | -0.6% | 276,900 |
| 2023/05/16 | 6,210 | 6,400 | 6,170 | 6,400 | +200 | +3.2% | 402,100 |
| 2023/05/15 | 6,160 | 6,210 | 6,150 | 6,200 | -10 | -0.2% | 257,300 |
| 2023/05/12 | 6,200 | 6,280 | 6,070 | 6,210 | +50 | +0.8% | 396,300 |
| 2023/05/11 | 6,160 | 6,210 | 6,150 | 6,160 | -60 | -1% | 171,200 |
| 2023/05/10 | 6,280 | 6,290 | 6,200 | 6,220 | -70 | -1.1% | 169,700 |
| 2023/05/09 | 6,240 | 6,310 | 6,230 | 6,290 | +60 | +1% | 184,900 |
| 2023/05/08 | 6,290 | 6,290 | 6,190 | 6,230 | ±0 | ±0% | 204,500 |
| 2023/05/02 | 6,300 | 6,320 | 6,190 | 6,230 | -40 | -0.6% | 148,500 |
| 2023/05/01 | 6,260 | 6,290 | 6,220 | 6,270 | +70 | +1.1% | 199,800 |
| 2023/04/28 | 6,190 | 6,260 | 6,180 | 6,200 | +70 | +1.1% | 205,800 |
| 2023/04/27 | 6,090 | 6,140 | 6,060 | 6,130 | -10 | -0.2% | 157,800 |
| 2023/04/26 | 6,200 | 6,270 | 6,120 | 6,140 | -100 | -1.6% | 280,700 |
| 2023/04/25 | 6,180 | 6,290 | 6,140 | 6,240 | +60 | +1% | 271,300 |
| 2023/04/24 | 6,220 | 6,240 | 6,160 | 6,180 | -10 | -0.2% | 245,500 |
| 2023/04/21 | 6,070 | 6,250 | 6,040 | 6,190 | +120 | +2% | 342,100 |
| 2023/04/20 | 6,230 | 6,230 | 6,010 | 6,070 | +20 | +0.3% | 353,800 |
| 2023/04/19 | 6,020 | 6,110 | 5,980 | 6,050 | -70 | -1.1% | 273,000 |
| 2023/04/18 | 6,160 | 6,230 | 6,090 | 6,120 | +40 | +0.7% | 262,400 |
| 2023/04/17 | 6,150 | 6,230 | 6,060 | 6,080 | -130 | -2.1% | 342,300 |
| 2023/04/14 | 6,220 | 6,270 | 6,160 | 6,210 | +290 | +4.9% | 728,100 |
| 2023/04/13 | 5,830 | 5,930 | 5,810 | 5,920 | +60 | +1% | 345,300 |
| 2023/04/12 | 5,830 | 5,880 | 5,820 | 5,860 | +110 | +1.9% | 413,700 |
| 2023/04/11 | 5,750 | 5,800 | 5,710 | 5,750 | ±0 | ±0% | 235,000 |
| 2023/04/10 | 5,730 | 5,750 | 5,700 | 5,750 | +50 | +0.9% | 185,800 |
| 2023/04/07 | 5,790 | 5,790 | 5,690 | 5,700 | -50 | -0.9% | 160,600 |
| 2023/04/06 | 5,690 | 5,770 | 5,650 | 5,750 | +40 | +0.7% | 301,200 |
| 2023/04/05 | 5,900 | 5,900 | 5,710 | 5,710 | -190 | -3.2% | 242,400 |
| 2023/04/04 | 5,920 | 5,920 | 5,820 | 5,900 | +20 | +0.3% | 260,100 |
| 2023/04/03 | 5,850 | 5,940 | 5,840 | 5,880 | +50 | +0.9% | 323,200 |
| 2023/03/31 | 5,820 | 5,850 | 5,750 | 5,830 | ±0 | ±0% | 347,100 |
| 2023/03/30 | 5,880 | 5,900 | 5,780 | 5,830 | -110 | -1.9% | 226,800 |
| 2023/03/29 | 5,940 | 5,940 | 5,850 | 5,940 | +10 | +0.2% | 309,000 |
| 2023/03/28 | 5,940 | 5,960 | 5,870 | 5,930 | +30 | +0.5% | 263,400 |
| 2023/03/27 | 5,920 | 5,980 | 5,880 | 5,900 | -10 | -0.2% | 242,600 |
| 2023/03/24 | 5,890 | 5,930 | 5,860 | 5,910 | +30 | +0.5% | 240,000 |
| 2023/03/23 | 5,900 | 5,920 | 5,850 | 5,880 | -70 | -1.2% | 319,500 |
| 2023/03/22 | 5,950 | 6,020 | 5,900 | 5,950 | +100 | +1.7% | 425,500 |
| 2023/03/20 | 5,860 | 6,000 | 5,780 | 5,850 | -140 | -2.3% | 680,800 |
| 2023/03/17 | 5,600 | 6,010 | 5,590 | 5,990 | +610 | +11.3% | 1,473,300 |
| 2023/03/16 | 5,360 | 5,420 | 5,260 | 5,380 | -50 | -0.9% | 602,400 |
| 2023/03/15 | 5,510 | 5,570 | 5,430 | 5,430 | -30 | -0.5% | 391,900 |
| 2023/03/14 | 5,540 | 5,540 | 5,410 | 5,460 | -110 | -2% | 433,100 |
| 2023/03/13 | 5,660 | 5,700 | 5,530 | 5,570 | -120 | -2.1% | 519,700 |
| 2023/03/10 | 5,740 | 5,790 | 5,680 | 5,690 | -150 | -2.6% | 636,400 |
| 2023/03/09 | 5,910 | 5,920 | 5,830 | 5,840 | -30 | -0.5% | 435,600 |
501～
550
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
